skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I guess I'll hold on until the dividend date. But PUR was one of my largest positions even before the takeover offer. As such it is now about 10% of my portfolio. My question is how long do you think the takeover will take and in my position, would you just err on the side of safety and take the considerable money and run. Also, although I have held PUR for a long time, your continued endorsement of the company made it easier to continue to hold through the recent drop and I thank-you for that.
Read Answer Asked by Alex on December 13, 2017
Q: I have a question about DHX and specifically DHX.DB.

The debentures are trading around $94 and have a coupon of 5.875% coming due in 2024.

Do you think the company is sound enough to be around in 2024 assuming no take over?

Would these debentures be a good investment for the more speculative part of a fixed income portfolio? If not, any suggestions?

Regards
John
Read Answer Asked by John on December 13, 2017
Q: The Globe Investor has the target price on PBH as $106.50 based on analysts polled by Zacks Investment Research (6 month time horizon, updated daily). On BNN yesterday, the caller asked for the street consensus target, which was $116.50. Pretty large difference = $10. Is it simply the 6 month target price vs a 12 month target price? Thanks...Steve
Read Answer Asked by Stephen on December 12, 2017
Q: I looked at PUR, liked the business, but found it pricey and chose to wait. A bad call I suppose. I realize Xylem will realize cost savings on the acquisition, and will no doubt see opportunities to expand PUR's business within its portfolio, but please help me understand something. I estimate Xylem is paying over 20 times PUR's expected 2017 EBITDA. I thought 10 to 11 times was "high". Isn't $9.00 exceptionally pricey? What can I take away from this? Thank you for your time. Edward.
Read Answer Asked by Edward on December 12, 2017
Q: Hello Peter and Team,

I do like BCI quite a bit as people need glasses. It's one of those boring areas of the market that is a necessity. A couple questions though:
Would BCI be considered a staple or a discretionary stock? I feel like it should be a staple as vision is not something I would forgo.
As well, in your report there isn't any mention of how laser surgery is affecting a market. I do know quite a few people that have undergone laser surgery and who widely recommend it to others. How much is laser surgery affecting the marketplace? And how is cheap alternatives online affecting the marketplace?

Thank you for your great service as always!

Wes

Read Answer Asked by Wes on December 11, 2017